As it has been widely accepted that impaired mitochondrial respiratory activity is a key inducer for the development of insulin resistance, it is reasonable that a pharmacological dose of metformin can improve insulin resistance by activating AMPK [61]. Here, PRKAA1 is linked to Insulin resistance.